Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Philip Perera"'
Publikováno v:
Neuropsychiatric Disease and Treatment. 19:811-828
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52eff9cd09e5492cd691b99c0ff80346
https://doi.org/10.2147/ndt.s402831
https://doi.org/10.2147/ndt.s402831
Publikováno v:
The Journal of Clinical Psychiatry. 66:34-40
Objective: To assess the efficacy and tolerability of controlled-release paroxetine (paroxetine CR) in the treatment of adults with panic disorder. Method: Paroxetine CR (25-75 mg/day; N = 444) was compared with placebo (N = 445) in patients with DSM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17c509f4bebf490d94cb6bcde7d9102a
https://doi.org/10.4088/jcp.v66n0105
https://doi.org/10.4088/jcp.v66n0105
Autor:
Philip Perera, Cornelius D. Pitts, Teresa A. Pigott, Madhukar H. Trivedi, Kerry E. Dillingham, Michelle L. Carfagno
Publikováno v:
The Journal of Clinical Psychiatry. 65:1356-1364
CONTEXT Paroxetine controlled release (CR) is approved for the treatment of major depressive disorder (MDD) in the dosage range of 25 to 62.5 mg daily. However, lower daily doses (12.5 mg and 25 mg) of this formulation have not been investigated in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2beb60b78177ea20591f800eb1afbc7e
https://doi.org/10.4088/jcp.v65n1010
https://doi.org/10.4088/jcp.v65n1010
Autor:
David J. Carpenter, Philip Perera, Joseph P. Horrigan, Alan Lipschitz, Regan Fong, Stan Krulewicz, Karen Dineen Wagner
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry. 45(4)
Objective This retrospective analysis of electrocardiographic (ECG) data investigated the cardiovascular effects of paroxetine 10-50 mg/day in pediatric patients (7-18 years of age). Data were collected from three 8- to 10-week, randomized, placebo-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ce34ba7464572b509ec01a6062b8243
https://pubmed.ncbi.nlm.nih.gov/16601647
https://pubmed.ncbi.nlm.nih.gov/16601647
Publikováno v:
The Journal of clinical psychiatry. 66(10)
Background Because of the poor quality of mental health care received by minorities, analyses documenting comparable response to and tolerability of medications for anxiety and depression in large samples of minority and majority populations could in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ac4e46e6a7e430d30097f21f02d109
https://pubmed.ncbi.nlm.nih.gov/16259535
https://pubmed.ncbi.nlm.nih.gov/16259535
Publikováno v:
The Journal of clinical psychiatry. 66(1)
To assess the efficacy and tolerability of controlled-release paroxetine (paroxetine CR) in the treatment of adults with panic disorder.Paroxetine CR (25-75 mg/day; N = 444) was compared with placebo (N = 445) in patients with DSM-IV panic disorder w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e754bbb945f96ef79bc95dcdf5bd02d4
https://pubmed.ncbi.nlm.nih.gov/15669886
https://pubmed.ncbi.nlm.nih.gov/15669886
Publikováno v:
Primary care companion to the Journal of clinical psychiatry. 1(5)
BACKGROUND: New medications that enter the marketplace have been tested almost exclusively in controlled clinical trials conducted in specialty research settings. There is some concern that these carefully selected patient samples may not provide inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096cbbcf35c100501ef410d9a88ca912
https://pubmed.ncbi.nlm.nih.gov/15014677
https://pubmed.ncbi.nlm.nih.gov/15014677